Bausch Health Companies Inc.(BHC)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Bausch Health Companies Inc. (BHC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BHC at 54.1/100 on a 32-signal composite quality model, placing it at rank #1,350 of 2,960 stocks — the top half of the AI-ranked universe. BHC scores in the top quartile across revenue scale (87.2), earnings quality (78.5). Areas of concern include profitability (18.2) and balance sheet strength (24.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 39.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Bausch Health Companies Inc. reports quarterly revenue of $2.9B, net income of $258.0M, free cash flow of $593.0M. Top institutional holders of BHC by reported 13-F value include PAULSON, GOLDENTREE ASSET MANAGEMENT, ROYAL BANK OF CANADA, based on the most recent SEC filings. BHC trades on the NYSE exchange and files with the SEC under CIK 885590. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bausch Health Companies Inc. directly from SEC EDGAR.